Immediate Impact
5 by Nobel laureates 63 standout
Citing Papers
Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis
2022 Standout
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
2022 Standout
Works of Y.A.S. Sens being referenced
Antibody response to the non‐adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients
2012
Paulista registry of glomerulonephritis: 5-year data report
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Y.A.S. Sens | 90 | 66 | 52 | 96 | 15 | 363 | |
| Jean-Marie Idatte | 62 | 96 | 82 | 79 | 18 | 319 | |
| M. de la Torre | 107 | 26 | 53 | 46 | 28 | 328 | |
| G. Liapi | 99 | 45 | 91 | 38 | 22 | 394 | |
| G J Wenting | 128 | 46 | 25 | 66 | 21 | 368 | |
| Franck Martinez | 121 | 25 | 81 | 137 | 11 | 380 | |
| Luiz E. Ianhez | 44 | 35 | 89 | 73 | 18 | 409 | |
| D. Morel | 114 | 44 | 95 | 64 | 28 | 373 | |
| J. S. Cheigh | 93 | 23 | 68 | 54 | 21 | 360 | |
| Virginie Masse | 52 | 17 | 48 | 55 | 14 | 386 | |
| Melissa Bleicher | 143 | 51 | 17 | 67 | 11 | 412 |
All Works
Loading papers...